In this interview, Magnus Back, MD, PhD delves into the involvement of specialized pro-resolving mediators (SPMs) in the progression of aortic valve stenosis, and the reduced accumulation of omega-3. He also talks about his research on resolvins, their receptors, and ways to facilitate the resolution of inflammation without inducing immunosuppression. Additionally, Dr. Back discusses his recent work on the use of SPMs in treating hospitalized COVID-19 patients.
Magnus Back, MD, PhD, is a Professor of Cardiology at Karolinska Institute.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
